Education
About Us
Working with TipRanks
Follow Us
Alterola Biotech (ABTI)
OTHER OTC:ABTI
Total Valuation
Alterola Biotech has a market cap or net worth of $7.44M. The enterprise value is $8.85M.
Market Cap$7.44M
Enterprise Value$8.85M
Share Statistics
Alterola Biotech has 1,459,502,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,459,502,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alterola Biotech’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.98%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.98%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee0.00
Profits Per Employee-1.74M
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alterola Biotech is ―. Alterola Biotech’s PEG ratio is 0.30.
PE Ratio―
PS Ratio0.00
PB Ratio3.49
Price to Fair Value3.49
Price to FCF-29.87
Price to Operating Cash Flow-3.95
PEG Ratio0.30
Income Statement
In the last 12 months, Alterola Biotech had revenue of 0.00 and earned -1.54M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-1.90M
Pretax Income-1.70M
Net Income-1.54M
EBITDA-1.70M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -874.20K and capital expenditures -18.90K, giving a free cash flow of -893.10K billion.
Operating Cash Flow-874.20K
Free Cash Flow-893.10K
Free Cash Flow per Share>-0.01
Dividends & Yields
Alterola Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-25.56
52-Week Price Change0.00%
50-Day Moving Average0.20
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Alterola Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Alterola Biotech as a current ratio of 0.11, with Debt / Equity ratio of 14.01%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap0.04
Net Debt to EBITDA-0.83
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Alterola Biotech has paid -154.52K in taxes.
Income Tax-154.52K
Effective Tax Rate0.09
Enterprise Valuation
Alterola Biotech EV to EBITDA ratio is -21.59, with an EV/FCF ratio of -31.06.
EV to Sales0.00
EV to EBITDA-21.59
EV to Free Cash Flow-31.06
EV to Operating Cash Flow-35.24
Balance Sheet
Alterola Biotech has $9.10K in cash and marketable securities with $1.55M in debt, giving a net cash position of -$1.54M billion.
Cash & Marketable Securities$9.10K
Total Debt$1.55M
Net Cash-$1.54M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alterola Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―